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We have previously shown that only endotheliotropic strains of human cytomegalovirus (HCMV), such as
TB40E, infect monocytes and impair their chemokine-driven migration. The proteins encoded by the UL128-
131A region (UL128, UL130, and UL131A) of the HCMV genome, which assemble into a pentameric gH-gL-
UL128-UL130-UL131A envelope complex, have been recognized as determinants for HCMV endothelial cell
tropism. The genes for these proteins are typically inactivated by mutations in all fibroblast-adapted strains
that have lost the diversified tropism of clinical isolates. By using mutant HCMV reconstituted from TB40E-
derived bacterial artificial chromosomes (BAC) encoding a wild-type (wt) or mutated form of UL128, we show
here that UL128-131A products are essential determinants of infection in monocytes and that pUL128, in
particular, can block chemokine-driven motility. The virus BAC4, encoding wt UL128, established infection in
monocytes, induced the intracellular retention of several chemokine receptors, and rendered monocytes
unresponsive to different chemokines. In contrast, the virus BAC1, encoding a mutated UL128, failed to infect
monocytes and to downregulate chemokine receptors. BAC1-exposed monocytes did not express immediate-
early (IE) products, retained virions in cytoplasmic vesicles, and exhibited normal chemokine responsiveness.
A potential role of second-site mutations in the observed phenotype was excluded by using the revertant viruses
BAC1rep and BAC4mut. By incubating noninfected monocytes with soluble recombinant pUL128, we observed
both the block of migration and the chemokine receptor internalization. We propose that among the gH-gL-
UL128-UL130-UL131A complex subunits, the UL128 protein is the one that triggers monocyte paralysis.
Human cytomegalovirus (HCMV) is a betaherpesvirus
found in 50 to 85% of the human population (7). HCMV
infects only humans, and primary infection results in the es-
tablishment of a lifelong persistent infection. During persis-
tence, either reactivations may occur from established latency
or constant low-level HCMV replication may take place in
particular cell types (14). With its large genome of approxi-
mately 240 kbp, encoding over 200 gene products, HCMV
displays the most genetic complexity among the eight human
herpesviruses (9). The large proportion of genes dedicated to
interaction with the host may justify the uncommon ability of
HCMV to infect a broad spectrum of cell types in vivo, includ-
ing epithelial and endothelial cells, fibroblasts, monocytes,
macrophages, dendritic cells, hepatocytes, myocytes, neurons,
and glial cells.
In particular, monocytes represent a key cell type for HCMV
infection, and they have been described as a potential site of
latency and as efficient vehicles for viral dissemination (5, 26,
28, 29, 33, 34). In previous work, we provided evidence that a
large percentage of human monocytes are susceptible to infec-
tion by endotheliotropic strains of HCMV and that as a result
of mere contact with the virus, monocytes show a severe im-
pairment of chemokine-driven migration (11). Since monocyte
migration is fundamental for biological processes and is critical
for the pathogenesis of several diseases, it is important to
understand which mechanisms are used by HCMV to interfere
with monocyte motility. Responsiveness to chemokines de-
pends upon the expression of chemokine receptors on the cell
surface (4, 21, 22). We observed that endotheliotropic strains
of HCMV, such as TB40E and clinical isolates, rapidly and
specifically downregulated CCR1, CCR2, CCR5, and CXCR4
on the surface of monocytes. Neither viral gene expression nor
soluble factors produced during HCMV infection were respon-
sible for these alterations, which were therefore attributed to a
structural component of the virus. Interestingly, the nonendo-
theliotropic laboratory strain AD169 was unable to induce
chemokine receptor downregulation, and monocytes main-
tained responsiveness to inflammatory (CCL5/RANTES,
CCL3/MIP-1a, CCL4/MIP-1b, and CCL2/MCP-1) and homeo-
static (CXCL12/SDF-1) chemokines (11).
In recent years, several independent studies have shown that
for infection of epithelial and endothelial cells, polymorpho-
nuclear leukocytes, and dendritic cells, HCMV depends on the
products of the three genes within the viral locus UL128-131A
(UL128, UL130, and UL131A). Disruption of any of the three
genes abolishes infection of endothelial cells (13, 27, 38, 39),
and conversely, repairing or complementing the mutation re-
generates the original tropism (13, 38). The rapid restriction of
tropism that accompanies HCMV fibroblast adaptation is ex-
plained by the emergence of disabling mutations in at least one
of the UL128-131A genes. In the aforementioned AD169
strain, for example, a frameshift mutation has been mapped
within the UL131A coding sequence (cds) (2).
The products of the UL128-131A genes have been charac-
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terized as structural components of the viral envelope (1, 17,
24, 39). In the model proposed by Ryckman et al. (24), the viral
glycoprotein gH, a type I transmembrane protein and a major
HCMV envelope fusion component, binds to glycoprotein L
(gL), pUL131A, and pUL130 through its ectodomain; pUL130
in turn binds pUL128 through noncovalent interactions. Thus,
the envelope of endotheliotropic strains contains the penta-
meric glycoprotein complex gH-gL-UL128-UL130-UL131A,
which is absent or incomplete in nonendotheliotropic strains
whose envelope includes either only gH-gL or the alternative
trimeric gH-gL-glycoprotein O (gO) complex.
In light of these data, the UL128-131A genes could be sus-
pected of being responsible for the chemokine receptor down-
regulation and migration block induced by HCMV in mono-
cytes. Here we directly addressed this issue and specifically
tested the hypothesis that pUL128 possesses monocyte-modu-
lating activity.
The phenotypes of viruses reconstituted from four bacterial
artificial chromosomes (BACs) harboring either an intact or
mutated UL128 cds within the backbone of one of two distinct
TB40E-derived clones were compared. In detail, BAC-derived
viruses TB40-BAC4 and TB40-BAC1, renamed BAC4 and
BAC1 for brevity (25), differ by the presence of an adenine
inserted at position 332 of UL128 in TB40-BAC1 that results
in a predicted truncation of pUL128. BAC-derived viruses
TB40-BAC4-UL128insA332 (shortened to BAC4mut) and
TB40-BAC1-UL128repaired (shortened to BAC1rep) (27),
were used as controls.
In addition, to check whether pUL128 could induce chemo-
kine receptor internalization and blocking of chemotaxis,
monocytes were treated with a soluble recombinant pUL128
protein (rpUL128) (16). Altogether, our results support a
model wherein contacts between pUL128 exposed on the
HCMV envelope and monocyte surface receptors are the trig-
gers of multiple chemokine receptor downregulation and mi-
gration block, in a process that is separable from virus entry.
MATERIALS AND METHODS
Cells. Primary human monocytes were isolated from peripheral blood by a
negative immunoselection procedure (monocyte isolation kit II; Miltenyi Biotec,
Bergisch Gladbach, Germany) and then cultured nonadherently in endotoxin-
free RPMI 1640 medium supplemented with 10% human AB serum, 2 mM
L-glutamine, 100 U/ml penicillin, and 100 U/ml streptomycin in polypropylene
tubes (Falcon; BD Biosciences, Le Pont de Claix, France) as previously described
(11). Human foreskin fibroblasts (HFF) were cultivated in minimal essential
medium (MEM) with 10% fetal calf serum (FCS; Gibco BRL, Grand Island,
NY), 2 mM L-glutamine, 100 U/ml penicillin, and 100 U/ml streptomycin. Cell
viability was determined by trypan blue (Biochrom, Berlin, Germany) exclusion.
Preparation of viral stocks and HCMV infection. Different HCMV variants
were used for the infection of monocytes (Table 1). The endotheliotropic strain
TB40E and the TB40E-derived BAC viruses TB40-BAC4, TB40-BAC1, TB40-
BAC4-UL128insA332, and TB40-BAC1-UL128repaired (called BAC4, BAC1,
BAC4mut, and BAC1rep, respectively, for the sake of brevity) were created,
extensively characterized, and kindly provided by C. Sinzger (27). Cell-free viral
stocks were prepared from supernatants of infected HFF and frozen at 80°C,
and then titers were determined by plaque assay as previously described (41).
Viral stocks were negative for contamination with Mycoplasma, as determined by
MycoAlert (Cambrex, Rockland, MD). UV-inactivated virus (subjected to 200 kJ
two times) (11) was used in the same manner as “live” virus. Monocytes were
infected at a multiplicity of infection (MOI) of 5 PFU per cell in complete
medium overnight.
UL128-131A sequence analysis. The UL128-UL131A regions of all viruses
used in this study were analyzed by sequencing of PCR products. Viral DNA was
purified from viral stocks with a High Pure viral nucleic acid kit (Roche Applied
Science, Mannheim, Germany) following the manufacturer’s instructions. One
microgram of viral DNA was then used as a template for PCR amplification
using the following primers: UL128for (5-TTGGATCACAGCCGCGTGC-3),
UL128rev (5-CCACGATCCGGGTTATCTTGTCG-3), UL130for (5-GCTA
ACGGCGAACCAGAATCC-3), UL130rev or UL131Arev (5-GGCTGTGAT
CCAATAACAGCCAC-3), and UL131Afor (5-CCCATCACCTCGCCTATA
CTATGTG-3). The PCR products were monitored by agarose gel
electrophoresis, and bands at the expected sizes were purified using a HiYield
PCR cleanup/gel extraction kit (SLG, Gauting, Germany). Sequencing was per-
formed by 4baseLab, Reutlingen, Germany. Finally, sequences were analyzed
and aligned using VectorNTI (Invitrogen, Eugene, OR).
Indirect immunofluorescence. To analyze the intracellular localization of viral
proteins as well as the distribution of cytoskeletal components, the following
monoclonal antibodies (MAbs) were used: anti-immediate-early 1-2 (anti-IE
1-2), anti-pp65 (Argene-Biosoft, Varilhes, France), and anti-vimentin (Onco-
gene Research Products, Boston, MA). Actin was detected by using BODIPY FL
phallacidin (Molecular Probes). At 24 h postinfection, monocytes were washed,
resuspended in phosphate-buffered saline (PBS), and allowed to adhere to glass
slides for 30 min at 37°C prior to fixation/permeabilization with ice-cold meth-
anol-acetone (1:1) or with 4% paraformaldehyde (PFA)–PBS–0.2% Triton for
investigation of the cytoskeletal proteins. Monocytes were incubated first with
MAbs for 60 min at 37°C and then with Alexa Fluor488-conjugated goat anti-
mouse immunoglobulins (Molecular Probes). Nuclear and cytoplasmic counter-
staining was performed with 4,6-diamidino-2-phenylindole (DAPI) and Evans
blue (Sigma-Aldrich, Munich, Germany), respectively. Microphotographs were
generated with a Zeiss Observer.Z1 microscope (Zeiss, Oberkochen, Germany).
Electron microscopy. Monocytes were infected at an MOI of 50 for 1 h or 24 h
prior to high-pressure freezing in cellulose capillary tubes (inner diameter, 200
m) as previously described (37). Briefly, the cellulose tubes were filled with the
monocyte suspension by capillary forces, cut to a length of 2 mm, and loaded in
standard aluminum cups. The cavities between cellulose tubes and aluminum
cups were filled with hexadecane. High-pressure freezing was performed with an
HPF 01 freezing apparatus (Engineering Office M. Wohlwend GmbH, Switzer-
land). Samples were freeze substituted in acetone containing 0.1% (wt/vol)
uranyl acetate, 0.2% (wt/vol) osmium tetroxide, and 5% (vol/vol) water and
embedded in Epon (8, 37). After being thin sectioned, samples were imaged
with a Zeiss EM10 transmission electron microscope at an acceleration volt-
age of 80 kV.
Western blot analysis. Monocytes were lysed for 30 min on ice with lysis
solution (50 mM Tris, pH 7.4, 150 mM NaCl, 5 mM EDTA, 0.5% Nonidet P-40)
containing protease inhibitors and dithiothreitol (DTT). Viral stocks were cen-
trifuged for 1 h at 14,000 rpm, and pellets were lysed for 30 min on ice with RIPA
buffer containing protease inhibitors. Lysis was followed by freezing the samples
at 80°C for 1 h and thawing them by sonication. Protein concentrations were
determined with a precision Red Advance protein assay (Cytoskeleton, Denver,
CO). Equal amounts of cell or viral extracts were separated in 12% SDS-
polyacrylamide gels and blotted onto nitrocellulose membranes (Bio-Rad Lab-
oratories, Munich, Germany). Membranes were blocked with PBS containing
0.3% Tween 20 and 5% dry milk powder and incubated with the indicated
monoclonal or polyclonal antibodies followed by peroxidase-conjugated goat
anti-mouse or goat anti-rabbit IgGs (Pierce Biotechnology, Rockford, IL). A
MAb specific for pUL128 (MAb 17) was a gift from Giuseppe Gerna (Fonda-
zione IRCCS Policlinico San Matteo, Pavia, Italy). Rabbit polyclonal antisera
TABLE 1. Summary of viral propertiesa
Virus Abbreviation
Tropism for
human
umbilical
vein endothelial
cellsb
Description of UL128
TB40E  wt
TB40E-BAC4 BAC4  wt
TB40E-BAC4-UL
128insA332
BAC4mut  In vitro A insertion
at nt 332
TB40E-BAC1 BAC1  Natural A insertion
at nt 332
TB40E-BAC1-UL
128repaired
BAC1rep  In vitro A deletion
at nt 332
a The wt UL130 and UL131A sequences were present in all viruses.
b All viruses had tropism for HFF.
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directed against gH, gL, pUL130, and pUL131A were gifts from Brent Ryckman
(Oregon Health and Science University, Portland, OR). For detection of cellular
components of the cytoskeleton, anti-actin (Sigma-Aldrich, St. Louis, MO),
anti--tubulin (Molecular Probes, Eugene, OR), anti-vimentin (Oncogene Re-
search Products, Boston, MA), and anti-WASP (Santa Cruz Biotechnology,
Santa Cruz, CA) were used. A chemiluminescence detection kit (SuperSignal
West Dura; Pierce Biotechnology) was used according to the manufacturer’s
instructions.
Flow cytometry. Analysis of chemokine receptor expression was performed as
previously described (11). Briefly, monocytes were incubated for 1 h in blocking
buffer (10% human immunoglobulin [Flebogamma; Grifols Deutschland GmbH,
Langen, Germany], 3% FCS, and 0.01% sodium azide in PBS) containing spe-
cific antibodies directed against CD14, CCR1, CCR2, or CCR5 (R&D Systems,
Minneapolis, MN), followed by a 45-min incubation with phycoerythrin (PE)-
conjugated rabbit anti-mouse immunoglobulins (DAKOCytomation, Hamburg,
Germany). Isotype-matched immunoglobulins (R&D Systems) were used as
controls. For determination of the total (cell surface and intracellular) chemo-
kine receptor proteins, monocytes were fixed and permeabilized with a Cytofix/
Cytoperm kit (BD Biosciences, San Diego, CA) prior to incubation with primary
MAbs or isotype-matched controls. Data were analyzed using CELLQuest soft-
ware (BD Biosciences), and for each antigen, the expression level was measured
as the percentage of positive cells as well as the mean fluorescence intensity
(MFI) for the respective antibody compared to the isotype-matched control.
Chemotaxis assay. Human recombinant chemokines CCL2/MCP1 and CCL5/
Rantes (R&D Systems) were used at a final concentration of 100 ng/ml in RPMI
1640–1% FCS. N-Formyl-Met-Leu-Phe (fMLP; Sigma-Aldrich) at a final con-
centration of 108 M served as a positive control. Cell migration was evaluated
with a 48-well Boyden chamber (Neuroprobe, Pleasanton, CA) with 5-m-pore-
size polycarbonate filters. Stimuli were assayed in triplicate, and the number of
cells that migrated in five visual fields (original magnification,100) was counted
for each well as previously described (11, 31). For each experiment, the results
are expressed as means for three replicates  standard deviations (SD).
Statistical analysis. Statistical analysis of the results was performed using a
paired, two-tailed Student t test, setting the level of statistical significance to P
values of 0.05.
RESULTS
UL128-131A are essential for infection of primary human
monocytes. In our previous work, we have shown that periph-
eral blood monocytes are susceptible to in vitro infection by
endotheliotropic HCMV strains, such as TB40E and clinical
isolates, but resistant to fibroblast-adapted strains (11). Since it
has become clear that the viral genes UL128-131A define en-
dothelial and epithelial cell tropism (12, 13), we decided to
investigate whether the gene products are also determinants of
monocyte susceptibility to HCMV infection and whether they
are involved in chemokine receptor downregulation and block-
ing of migration.
For this purpose, we took advantage of 4 different TB40E
BAC derivatives that were recently characterized for the ability
to infect endothelial cells (25, 27). BAC-derived viruses TB40-
BAC4 and TB40-BAC1 (BAC4 and BAC1) differ by two point
mutations within UL128: an adenine-to-cytosine change at nu-
cleotide position 282 and an adenine insertion at nucleotide
position 332 of the UL128 cds in BAC1 (27). The 332A inser-
tion is located within the second exon and causes a frameshift
resulting in a truncated pUL128 protein (27). BAC-derived
revertant viruses TB40-BAC4-UL128insA332 (BAC4mut) and
TB40-BAC1-UL128repaired (BAC1rep) (27), engineered to
reproduce the UL128 sequences found in BAC1 and BAC4
within the otherwise unchanged BAC4 and BAC1 backbones,
respectively, were used as controls. As summarized in Table 1,
BAC4 and BAC1rep, carrying the wild-type (wt) UL128 se-
quence and an overall functional UL128-131A locus, exhibited
full tropism for endothelial cells, whereas BAC1 and
BAC4mut, harboring the disabling mutation within UL128, did
not infect endothelial cells.
Monocytes were inoculated at an MOI of 5 with the four
viruses, and at 24 h postinfection (p.i.), the initiation of the
viral cycle was determined by detection of IE 1-2 proteins in
the monocyte nuclei. As shown in Fig. 1, the endotheliotropic
viruses BAC4 and BAC1rep were able to express IE gene
products in up to 60% of the monocytes, whereas no IE 1-2-
positive nuclei were detected in monocytes inoculated with the
nonendotheliotropic viruses BAC1 and BAC4mut.
The infectivity of the four viruses correlated with different
efficiencies of nuclear translocation of pp65, an HCMV tegu-
ment protein delivered rapidly into the nucleus after virus
entry (19). At 24 h p.i., pp65 was detected in the nuclei of
monocytes infected with BAC4 and BAC1rep but remained in
the cytoplasm of monocytes inoculated with the BAC1 and
BAC4mut viruses (Fig. 1).
To investigate the fate of the viral particles, ultrastructural
analysis of infected monocytes was performed by electron mi-
croscopy. All four viruses were internalized into monocytes,
and shortly after infection, numerous virions and dense bodies
accumulated in large vacuoles in the monocyte cytoplasm, ir-
respective of the virus used. At 1 h p.i., monocytes infected by
BAC4 were undistinguishable from those inoculated with
BAC1 (Fig. 2). At 24 h p.i., however, BAC1 viral particles were
still present in large vesicles, while BAC4 viral particles were
not visible anymore, consistent with the virions carrying the
pentameric gH-gL-UL128-UL130-UL131A complex being re-
leased from the vesicles and uncoated.
Altogether, these data demonstrate for the first time that an
intact UL128-131A region is necessary to establish HCMV
infection of monocytes. Since monocytes are not productively
infected by HCMV, as they are not permissive for the entire
replicative cycle of the virus (20), it was not possible to mea-
sure viral growth/release in these cells. Here and throughout
this work, we therefore define HCMV-infected cells as those
cells that show expression of IE 1-2 products and nuclear
translocation of pp65.
UL128 mutation suppresses pentameric gH-gL-UL128-
UL130-UL131A complex incorporation into HCMV virion en-
velope. Since pUL128 is part of the pentameric gH-gL-UL128-
UL130-UL131A complex, it was important to define the
impact of UL128 mutations on the actual complex composition
found in HCMV virions. For this purpose, purified viral par-
ticles of the four BAC viruses were analyzed in Western blots
for their content of gH, gL, pUL128, pUL130, and pUL131A.
As shown in Fig. 3, while BAC4 and BAC1rep virions showed
the same complex composition as TB40E, with all five subunits
present, BAC4mut and BAC1 virions did not contain pUL128,
pUL130, and pUL131. A parallel analysis of UL128-131A
product synthesis by the HCMV-infected fibroblast cells used
to produce virions was performed (data not shown). BAC4-
and BAC1rep-infected fibroblasts contained all three proteins
(pUL128 to pUL131A), as expected. BAC4mut- and BAC1-
infected fibroblasts, on the other hand, accumulated levels of
pUL130 and pUL131A similar to those found in BAC4 and
BAC1rep infections, while a truncated pUL128 form was not
found.
Overall, this analysis suggests that the truncated pUL128
protein encoded by BAC4mut and BAC1 viruses is unstable
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and therefore undetectable by immunoblotting. The absence
of pUL128 more generally inhibits the incorporation of
pUL130 and pUL131A into the viral envelope.
pUL128 is necessary to impair the chemokine-driven migra-
tion of monocytes. We previously observed that the mechanism
used by TB40E to inhibit the chemokine-driven migration of
monocytes was independent of viral gene expression but was
dependent on exposure to some structural component of the
viral particles (11). To test the possible involvement of the
UL128-131A proteins, monocytes were inoculated for 24 h at
an MOI of 5 with all four viruses prior to the measurement of
monocyte chemotaxis. As shown in Fig. 4A, only BAC4 and
BAC1rep inhibited CCL2- and CCL5-driven chemotaxis,
whereas BAC4mut and BAC1 did not. The inhibitory effect
was specific for chemokine-driven migration, as none of the
viruses affected basal migration or the responsiveness to fMLP
(Fig. 4A and B). Exactly identical patterns were obtained by
using UV-inactivated, replication-incompetent viruses (data
not shown), thus confirming our previous results that de novo
viral gene expression is not required for the block of migration.
A conservative interpretation of these results is that the
structural component responsible for monocyte paralysis be-
longs to the UL128-131A region. To address the issue of a
FIG. 1. UL128 to UL131A are determinants of HCMV tropism in monocytes. (A) Human primary monocytes were inoculated at an MOI of
5 with BAC4, BAC4mut, BAC1, and BAC1rep. At 24 h postinfection, the viral IE 1-2 and early-late (pp65) antigens were detected by indirect
immunofluorescence staining (green). Mock-infected monocytes served as controls. All pictures (original magnification, 60) are representative
of 5 donors. Cell nuclei were counterstained with DAPI, and the cytoplasm was counterstained with Evans blue (blue and red signals, respectively).
(B) In each experiment, the percentages of both IE- and pp65-positive nuclei were calculated by counting and correlating blue (DAPI) and green
(IE or pp65) nuclei in five randomly selected microscopic fields. (C) The percentage of pp65-positive cells was calculated by counting and
correlating blue (DAPI) nuclei and green (pp65) nuclei and cytoplasm in five randomly selected microscopic fields. Statistical analysis was
performed for 5 independent experiments.
FIG. 2. UL128-131A are necessary for release of viral particles
from endocytic vesicles. Monocytes were infected at an MOI of 50 with
BAC4 or BAC1. Ultrastructural analysis was performed at 1 h and 24 h
p.i. by electron microscopy after high-pressure freezing and freeze
substitution as described in Materials and Methods. Samples were
imaged with a Zeiss EM10 transmission electron microscope at an
acceleration voltage of 80 kV.
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specific role for pUL128 in migration inhibition, monocytes
were treated with increasing doses of soluble recombinant
pUL128 (rpUL128). Figure 4B shows that starting at a con-
centration of 1 ng/ml, rpUL128 blocked the CCL2- and CCL5-
driven migration of monocytes. Monocytes treated with
rpUL128 exhibited normal basal migration as well as normal
fMLP responsiveness. The inhibitory effect exhibited by
rpUL128 was specific (Fig. 4C), as monocytes treated with an
unrelated recombinant protein (rProtX, a hepatitis B virus
N-terminally His-tagged Pres1-Pres2 protein), produced and
purified in the same way as rpUL128 (16), migrated like mock-
infected untreated monocytes. Altogether, these data indicate
that pUL128 is specifically involved in inhibiting the chemo-
kine-driven migration of monocytes and that it does so even as
a soluble recombinant molecule without HCMV infection.
The block of chemokine-driven migration is not dependent
on modification of the cellular cytoskeleton. Since an intact
and functional cytoskeleton is a prerequisite for monocyte
migratory behavior, we investigated whether a defect in the
cytoskeletal architecture could account for the block of migra-
tion. Monocytes infected with BAC4 and BAC1rep were com-
pared to monocytes inoculated with BAC1 and BAC4mut re-
garding the total amount and architecture of the three main
components of the cytoskeleton, namely, actin, vimentin, and
tubulin. As shown in Fig. 5A, irrespective of the virus used, the
distributions of actin and vimentin appeared identical to those
in mock-infected cells, presenting as intense peripheral accu-
mulations of actin and vimentin with protruding spikes (short
plasma membrane extensions). Additionally, by Western blot
analysis, we observed that the total intracellular amounts of the
structural components actin, vimentin, and tubulin, as well as
the regulatory protein WASP (42), remained unaltered in
monocytes infected by all four viruses (Fig. 5B). Since all mono-
cytes exhibited the same cytoskeletal features, we can conclude
that HCMV infection of monocytes, in contrast to HCMV infec-
tion of monocyte-derived macrophages (10), does not induce dra-
matic alterations of the cytoskeletal architecture.
FIG. 4. pUL128 is necessary to block chemokine-driven migration of
monocytes. The chemotactic migration of monocytes toward the inflamma-
tory chemokines CCL5 and CCL2 (100 ng/ml) was evaluated using a Boyden
chamber as described in Materials and Methods. As controls, migration
toward fMLP (108 M) and basal/spontaneous migration (toward medium
alone) were evaluated. The numbers of cells that migrated were obtained
from at least 5 independent experiments using cells from different donors and
are means SD. (A) Only viruses carrying the wild-type UL128-131A locus
are able to impair monocyte chemotaxis. Monocytes were mock infected or
incubated overnight with BAC4, BAC4mut, BAC1, or BAC1rep at an MOI
of 5 prior to measurement of chemotaxis. *, P  0.05 compared to mock-
infected cells. (B) Soluble recombinant pUL128 impairs chemotaxis toward
CCL2 and CCL5. Monocytes were incubated overnight with increasing con-
centrations of rpUL128 prior to assessment of cell migration. Untreated
monocytes (n.t.) and monocytes infected with BAC4 (MOI of 5) were used as
controls. (C) The inhibitory effect of rpUL128 is specific. Monocytes were
infected with BAC4 or BAC1 (MOI of 5) or treated overnight with 1 g/ml
of rpUL128 or the irrelevant protein rProtX, and migration toward CCL2
and CCL5 was evaluated.
FIG. 3. Immunoblot of HCMV virions. Expression of gH, gL,
pUL128, pUL130, and pUL131A was investigated in the parental
TB40E virus and the four different TB40E-derived virus mutants en-
coding wild-type or mutant UL128. Viral stocks produced in HFF were
lysed in reducing buffer and resolved by SDS-PAGE, and proteins
were analyzed with MAb 17, directed against pUL128, or with rabbit
antisera directed against gH, gL, pUL130, and pUL131A.
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pUL128 is necessary to downregulate the surface expression
of chemokine receptors. We finally compared, by cytofluori-
metric analysis, the cell surface expression of different chemo-
kine receptors on monocytes inoculated with the four viruses
or treated with 1 g/ml of rpUL128 or rProtX. As shown in
Fig. 6A, the surface expression of CCR1, CCR2, and CCR5,
the cognate receptors for the CCL2 and CCL5 chemokines
used previously in migration assays, was strongly reduced in
monocytes infected with BAC4 and BAC1rep as well as in
monocytes treated with 1 g/ml of rpUL128. However, mono-
cytes inoculated with BAC4mut or BAC1 or treated with 1
g/ml of rProtX exhibited expression levels of CCR1, CCR2,
and CCR5 identical to those in mock-infected untreated
FIG. 5. Inhibition of monocyte migration is not due to cytoskeletal
modification. Monocytes were mock infected or incubated overnight
with BAC4, BAC4mut, BAC1, or BAC1rep (MOI of 5). (A) Morpho-
logical analysis of actin and intermediate (vimentin) filaments was
performed by indirect immunofluorescence at 24 h p.i. Monocyte nu-
clei are blue (DAPI staining), the cytoplasm is red (Evans blue stain-
ing), and actin and vimentin are green. Original magnification, 60.
The images are for one donor representative of three. (B) Western
blot analysis of major components of the monocyte cytoskeleton. Data
for one donor representative of five are shown. Equal protein amounts
of cell lysates were separated by SDS-PAGE, blotted onto nitrocellu-
lose membranes, and probed with antibodies raised against actin,
vimentin, tubulin, and WASP.
FIG. 6. pUL128 is necessary to downregulate the surface expres-
sion of chemokine receptors. Monocytes were mock infected or incu-
bated overnight with BAC4, BAC4mut, BAC1, or BAC1rep (all used
at an MOI of 5) or with rpUL128 or rProtX (both used at 1 g/ml).
The expression of the indicated chemokine receptors as well as of
CD14 was evaluated by fluorescence-activated cell sorter analysis of
viable or fixed-permeabilized cells for quantification of surface (A) and
total (B) protein amounts. The percentages of cells expressing the
indicated molecules were evaluated in independent experiments and
analyzed statistically. Values are means  SD for 5 independent ex-
periments. *, P  0.05 compared to mock-infected cells.
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monocytes. Under all conditions, monocytes showed high ex-
pression levels of CD14, indicating that the downregulation of
chemokine receptors was specific and also reflecting the purity
of the monocyte population.
To investigate whether the reduced cell surface expression
was dependent on receptor degradation or internalization, we
compared the total amounts of chemokine receptor proteins in
BAC4-infected and rpUL128-treated monocytes. As controls,
we considered mock-infected and rProtX-treated monocytes.
All cells—uninfected, infected, and treated with rpUL128 or
rProtX—were shown to possess the same amounts of chemo-
kine receptors after fixation and permeabilization (Fig. 6B),
thus indicating that the downregulation on the cell surface was
not due to protein degradation but to a redistribution of re-
ceptor molecules to intracellular compartments.
DISCUSSION
HCMV uses monocytes as an important target of infection,
subverting their roles in both innate and adaptive immune
responses. In fact, monocytes are regarded as a site of viral
latency in vivo (26, 30) and as vehicles for viral dissemination
(28, 32, 35). At present, little is known about the mechanisms
of HCMV entry and establishment of infection in these cells or
about the influence of HCMV on their functions. Monocytes
originate from CD34 progenitors in the bone marrow, circu-
late in the bloodstream for 1 to 3 days, and then move into
peripheral tissues in order to replenish the resident popula-
tions of tissue macrophages and dendritic cells. Monocytes can
encounter HCMV during all of these stages: in the bone mar-
row, in the bloodstream, and in the peripheral tissues during or
after transendothelial migration from the bloodstream. Mono-
cyte movements are tightly controlled by members of the su-
perfamily of chemoattractant cytokines called chemokines and
by their receptors (22). The deregulation of the chemokine-
chemokine receptor system can favor HCMV infection,
spread, and persistence in the host. Accordingly, more than 30
distinct virally encoded proteins have been identified that are
able to corrupt the chemokine system (15); in particular,
HCMV encodes two CXC chemokine homologues (18) and
four chemokine receptor homologues (36).
In previous work, we demonstrated that structural compo-
nents present in the viral particles of clinical isolates and en-
dotheliotropic HCMV strains account for the impaired expres-
sion and function of the cellular chemokine receptors CCR1,
CCR2, CCR5, and CXCR4 in monocytes (11). At that time, we
could not identify the specific viral factors involved. Recently,
the viral genes UL128, UL130, and UL131A have been shown
to be mutated consistently in all fibroblast-adapted strains and
to be essential for infection of endothelial, epithelial, and den-
dritic cells (1, 12, 13, 23, 38, 39). Importantly, the three en-
coded proteins have also been shown to be structural compo-
nents of the viral envelope. Wang and Shenk described
complexes containing gH/gL and the UL128 and UL130 pro-
teins in infected cells as well as in virions (39). Adler et al.
extended these studies by showing that UL131A is associated
with gH in virions (1). Finally, Ryckman et al. showed that
gH/gL and UL128-131A assemble to form one complex con-
sisting of all five proteins, modeled in the following way. gH
binds both gL and pUL130, thus forming a pocket for
pUL131A. pUL128 is not covalently bound to the other mem-
bers of the complex but is held in an exposed position by
pUL130 (24). We therefore investigated whether these three
proteins could be important for monocyte infection, on the one
hand, and whether they could play a role in impairment of
chemotaxis on the other. Since the UL128 gene encodes a
protein with a CC chemokine domain (13) and, moreover,
soluble recombinant pUL128 shows virus-inhibitory and cell
surface-binding properties (16), we hypothesized that pUL128
could have a particular role within the complex and could be
involved directly in chemokine receptor downregulation.
The TB40E-derived BAC4 and BAC1 viruses exhibit oppo-
site endothelial cell tropism properties, carry identical UL130
and UL131A sequences, and differ by the presence of a critical
adenine insertion within the UL128 cds of BAC1 (27). Re-
moval of the additional adenine in the genomic background of
BAC1, in the virus called BAC1rep, restored endothelial cell
tropism. Conversely, insertion of the additional adenine in the
genomic background of BAC4, in the virus called BAC4mut,
abolished endothelial cell tropism.
While BAC4 and BAC1rep were able to initiate the viral
cycle in primary human monocytes, the BAC1 and BAC4mut
viruses were not. Thus, the genetically pure and well-defined
BAC4 and BAC1 viruses and their derivatives nicely repro-
duced the phenotypic differences previously observed between
TB40E, its nonendotheliotropic counterpart AD169 (11), and
TB40F (our unpublished data), formally demonstrating that
the UL128-131A locus defines HCMV tropism for monocytes.
However, the inability to infect endothelial cells and mono-
cytes exhibited by BAC1 and BAC4mut cannot be referred
exclusively to the lack of UL128 product, because our analysis
of virion composition showed that in the absence of wild-type
UL128, the entire complex was altered. Mutation in UL128
leads to the joint lack of all three UL128-131A products from
the viral envelope. Our results are similar and consistent with
those of Ryckman et al. (24) showing that pUL128, pUL130,
and pUL131A must all bind simultaneously to gH/gL for the
production of complexes that can function in entry into epi-
thelial and endothelial cells. When any single component of a
multiprotein complex is missing or misfolded, the entire com-
plex is frequently retained in the endoplasmic reticulum (ER)
or is degraded by ER-associated degradation. Whereas HFF
infected by BAC1 and BAC4mut expressed pUL130 and
pUL131A, we did not detect full-length or shorter forms of
pUL128. It is probable that truncated pUL128 has a short
half-life because it is identified as misfolded and disposed of by
the ER quality control of the infected HFF.
An important point to be verified was whether the BAC1
and BAC4mut viruses were unable to enter monocytes or suf-
fered from a postentry block instead (i.e., an arrest at any stage
along the postfusion pathway of uncoating, virus particle trans-
location to the nuclear pores, and release of the viral genomes
into the nucleus). Earlier studies with endothelial and epithe-
lial cells established that pUL128-131A are essential for
HCMV fusion and entry. The specific site of fusion in these
cells seems to be influenced by the cell of origin of the virions.
For example, in Arpe-19 epithelial cells, endotheliotropic
HCMV entered by direct fusion at the plasma membrane if the
virions were produced in the same cell line but was endocyto-
sed and fused at endosomal membranes if virions were pro-
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duced in fibroblasts (40). In our experiments using viral stocks
produced in HFF, we observed both BAC4 and BAC1 virions
accumulating inside endosome-like structures in the cytoplasm
of monocytes by electron microscopy at early times p.i. These
vesicular structures retained BAC4 virions for only a limited
period, and at 24 h p.i., the cytoplasmic vesicles were filled by
an amorphous material that might represent the remains of the
uncoating process, but none contained intact virions. In con-
trast, at the same time point, BAC1 virion particles were re-
tained in large cisternae that nicely reflected the pattern given
by pp65 immunofluorescence staining. Therefore, monocytes
seem to mirror the features of the working model for endo-
thelial and epithelial cells in which fibroblast-produced HCMV
enters the cell by endocytosis and fuses with endosomal mem-
branes.
The data shown here lead to the hypothesis that the prod-
ucts of the UL128-131A locus are necessary to allow the fusion
of the endosomal membrane with the viral envelope. However,
an additional or alternative role of the UL128-131A products
in docking the virions to a specific receptor, thus mediating a
“nondegrading” type of endocytosis, cannot be excluded.
The mechanism linking the UL128-131A proteins to migra-
tion impairment and chemokine receptor downregulation in
HCMV-infected monocytes was analyzed in turn by testing the
expression and functionality of the chemokine receptors
CCR1, CCR2, and CCR5 in monocytes exposed to the four
clonal viruses. Both BAC4 and BAC1rep inhibited monocyte
migration toward CCL2 and CCL5 and induced surface down-
regulation of the cognate receptors CCR1, CCR2, and CCR5
through cytoplasmic accumulation. Importantly, the same hap-
pened when UV-inactivated BAC4 and BAC1rep virions were
used. In contrast, BAC1 and BAC4mut did not alter migration
or chemokine receptor expression on the cell surface. Since we
compared viruses expressing wt and mutated versions of
pUL128 in two different genomic backgrounds, we can rule out
the possibility that adventitious mutations outside UL128 are
involved in this phenomenon. Also, the observation that
BAC4- and BAC1rep-infected monocytes retained their basal
migration and fMLP responsiveness, together with a cytoskel-
etal structure comparable to that of uninfected cells, indicated
that the inhibition of migration was a selective effect. The
persistence of an intact cytoskeleton in infected monocytes was
surprising because HCMV infection of macrophages, which
are derived from monocytes, induces a dramatic alteration of
the cellular architecture (10).
These data indicated that a product(s) of the UL128-131A
locus is required for the chemotaxis inhibition and receptor
downregulation effects. However, these data did not allow us
to define whether any of the UL128-131A products are directly
responsible for chemotaxis inhibition or if they are required to
enable entry and the subsequent release of a critical compo-
nent (e.g., a tegument protein) into monocytes. A hint of a
direct role for pUL128 was obtained by treating uninfected
monocytes with a recombinant pUL128 protein (16) prior to
measurement of their chemotaxis and assessment of chemo-
kine receptor expression. The soluble rpUL128 protein po-
tently inhibited chemokine-driven migration as well as the sur-
face expression of the chemokine receptors CCR1, CCR2, and
CCR5.
This result suggests a couple of conclusions. First, pUL128
may be the only HCMV protein required to induce effects on
monocyte chemotaxis and chemokine receptors, and in our
experimental setting, its action does not require presentation
on the surface of the virion envelope. Second, its mechanism of
action is most probably dependent on physical interaction with
a cellular receptor(s). The hypothesis that pUL128 can bind
one or more chemokine receptors is particularly tempting be-
cause chemokine receptors have been known to undergo in-
ternalization by endocytosis (desensitization) after ligand
engagement. Alternatively, pUL128 could induce ligand-inde-
pendent internalization of other receptors of the family under
conditions of sustained signaling (heterologous desensitiza-
tion) (6). However, the observation that rpUL128 did not
induce calcium fluxes in monocytes (data not shown), together
with the broad spectrum of chemokine receptor downregula-
tion, supports the hypothesis that pUL128 activates a general
negative signaling pathway such as the protein kinase A (PKA)
or PKC pathway (3).
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